SUZANNE GAZDA M.D.
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact

Neurology
​Trends

Curcumin and the brain – is there a neuroprotective effect?

7/14/2021

0 Comments

 
Our brain and gut are inextricably linked as every day we see more and more research that supports the need to improve the health of our microbiome in order to protect our neurological processes too. As such, nutritional influences, both good and bad, play a large role in supporting our brain health – so, it was with great interest we recently noted some interesting items regarding curcumin.
Picture
Picture
Curcumin belongs to a family of chemical compounds known as curcuminoids, which is the principal bioactive component of turmeric that gives this spice its distinctive yellow color. You’ll find curcumin is frequently used in many Indian and Thai cuisine, adding a bright, appetizing color and deep flavor to many dishes. 
 
Curcumin’s anti-inflammatory properties have gained a good deal of attention in recent years as modern medicine looks to this mainstay of centuries-old practices as a possible aid in the fight against neurodegenerative disease and aging. As mentioned in an article in Psychology Today, “animal studies consistently show benefit of curcumin in reversing cognitive decline at the behavioral as well as the molecular level.” And curcumin compounds have been identified as exerting neuroprotective effects, blocking a specific cascade of inflammatory action in microglia, which primarily function as immune defense cells in our nervous system. In one particular study, scientists found that “curcumin inhibited the release of a protein known to kindle inflammation and lead to tissue damage associated with memory impairment. A number of inflammatory cascades are believed to play a role in Alzheimer’s disease.”
 
Other research has focused on how curcumin may be instrumental in improving certain brain processes. A double-blind, placebo-controlled study conducted over 18 months with the supplement Theracurmin® found that in patients who did have identified dementia, this bioavailable form of curcumin “led to significant attention and memory benefits.”1 Additionally, the FDDNP-PET scans performed pre- and post-treatment suggested that these behavioral and cognitive benefits are associated with decreases in plaque and tangle accumulation in brain regions modulating mood and memory. These findings led scientists to posit that curcumin’s cognitive benefits may stem from its anti-inflammatory and/or anti-amyloid brain effects.
 
Every day, science is gaining more understanding about how certain foods and dietary programs as well as specific supplements can truly enhance our health in so many ways. But before you make any nutritional changes or add anything new, especially if you are taking prescribed medications, always discuss it with your physician! You can learn more about diet and brain health and the role of inflammation in disease at: https://www.suzannegazdamd.com/blog/does-all-disease-begin-in-the-gut and be sure to search our blog library for additional related articles. 
 
In health,
Dr. Suzanne Gazda
 
1 Gary W. Small, Prabha Siddarth, Zhaoping Li, Karen J. Miller, Linda Ercoli, Natacha D. Emerson, Jacqueline Martinez, Koon-Pong Wong, Jie Liu, David A. Merrill, Stephen T. Chen, Susanne M. Henning, Nagichettiar Satyamurthy, Sung-Cheng Huang, David Heber, Jorge R. Barrio. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. The American Journal of Geriatric Psychiatry. Volume 26, Issue 3, 2018. https://doi.org/10.1016/j.jagp.2017.10.010.
https://www.sciencedirect.com/science/article/pii/S1064748117305110)

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    Author

    Dr. Suzanne Gazda, Integrative Neurology

    Archives

    February 2024
    January 2024
    November 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    December 2022
    November 2022
    September 2022
    April 2022
    November 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019

    Categories

    All

SITE MAP

HOME
MEET DR. GAZDA
OUR PRACTICE
INTEGRATIVE MEDICINE
OUR APPROACH
CONDITIONS WE TREAT
TREATMENT PROTOCOLS
PATIENT STORIES
FAQ
POLICIES & RATES
BLOG
SCIENTIFICALLY SPEAKING
MEDICAL RESOURCES
JOURNAL ARTICLES
LINKS
BECOME A PATIENT
CONTACT
NEWS
PRODUCT RECOMMENDATIONS

Location

San Antonio, Texas

Telephone

210-692-1245
Fax
210-692-9311

Email

[email protected]
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact